Laboratory studies suggest that GLP-1 receptor agonists can protect neurons from damage caused by toxic protein aggregates, excitotoxicity, and metabolic stressprocesses implicated in neurodegenerative conditions such as Alzheimer's disease and Parkinson's disease
Despite such a likely connection, only one study to date has assessed differences in markers of oxidative damage in children affected with konzo, where increased levels of 8,12-iso-iPF2-VI isoprostane in affected children was associated with deficits in neurocognition, but not deficits in motor impairment 3
Boost your beauty and wellness
[8] [9] For some patients, intensification of insulin therapy may be necessary
The medications themselves have not been shown to directly suppress milk production
Easy to take and the liposomal form is protected in the GI tract